- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01756365
Autologous Cultured Corneal Epithelium (CECA) for the Treatment of Limbal Stem Cell Deficiency (CECA)
Autologous Cultured Corneal Epithelium ( Culture d'épithélium cornéen Autologue CECA) for the Treatment of Unilateral Corneal Lesions Associated With Limbal Stem Cell Deficiency
The study " Autologous cultured corneal epithelium (CECA) for the treatment of corneal lesions associated with limbal stem cell deficiency" is the first clinical trial of this product manufactured at the LOEX laboratory. The culture of corneal epithelium strives to produce a reconstructed tissue with the therapeutical aim of treatment of limbal stem cell deficiency. The study is a phase I/phase II study with the goal to evaluate safety and efficacy of the CECA graft for the treatment of human patients suffering from limbal stem cell deficiency.
The trial is open to all genders. The inclusion of 5 minors is planned.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Québec, Canada, G1S 4L8
- Recruiting
- Centre universitaire d'Ophtalmologie CHU de Québec - HSS
-
Contact:
- Ralph Kyrillos, MD FRCS (C)
- Phone Number: 418-682-7573
- Email: ralph.kyrillos.1@ulaval.ca
-
Contact:
- Lucie Germain, PhD
- Phone Number: 61696 4185254444
- Email: lucie.germain@fmed.ulaval.ca
-
Principal Investigator:
- Ralph Kyrillos, MD FRCS (C)
-
-
Ontario
-
Toronto, Ontario, Canada, M5T 2S8
- Recruiting
- University Health Network - Toronto Western Hospital
-
Contact:
- Jennifer Coleman
- Phone Number: 5389 4163404800
-
Principal Investigator:
- Allan Slomovic, MD,FRCSC
-
-
Quebec
-
Montréal, Quebec, Canada, H1T 2M4
- Recruiting
- CIUSSS de l'Est de l'Ile de Montréal
-
Contact:
- Dorline Sokoundjou, MSc
- Phone Number: 7114 514-252-3400
- Email: bfv2.hmr@ssss.gouv.qc.ca
-
Principal Investigator:
- Isabelle Brunette, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
All genders
- Adults
- Minors
- LSCD in one or two eyes. A minimum of 1-3 mm2 of undamaged limbus is required for a biopsy to be taken without foreseeable adverse consequences for the donor eye
Exclusion Criteria:
- Donor eye not sufficiently healthy to allow for the harvesting of a 1-3 mm2 limbal biopsy without foreseeable consequences for the donor eye
- Pregnancy
- Breast-feeding
- Incapacitated person
- known allergy to aprotinine (Trasylol (R))
- Hypersensibility to bovine proteins
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: ACCE (Autologous Cultured Corneal Epithlium) graft for the treatment of corneal lesions
Surgical transplantation of Autologous Cultured Corneal Epithelium
|
The culture of corneal epithelium strives to produce a reconstructed tissue with the therapeutical aim of treatment of limbal stem cell deficiency.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Anatomic assessment
Time Frame: 1 year
|
Global severity score (Epithelial deficit, corneal opacity, peripheral and central vascularization, integrity of the ocular surface)
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Best corrected visual acuity
Time Frame: 1 year
|
Evaluation according to Snellen chart
|
1 year
|
Level of pain
Time Frame: 1 year
|
11 point numerical verbal scale
|
1 year
|
Quality of life measurements
Time Frame: 1 year
|
Health Utilities Index Mark 3
|
1 year
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ralph Kyrillos, MD FRCS (C), CHU de Quebec
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- LOEX 015
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Limbal Stem Cell Deficiency
-
The S.N. Fyodorov Eye Microsurgery State InstitutionRecruitingLimbal Stem-cell DeficiencyRussian Federation
-
University of California, Los AngelesNational Eye Institute (NEI); California Institute for Regenerative Medicine...Recruiting
-
National Taiwan University HospitalRecruiting
-
Siriraj HospitalOsaka UniversityCompletedLimbal Stem-cell DeficiencyThailand
-
CellSeed France S.A.R.L.FGK Clinical Research GmbHWithdrawnLimbal Stem Cell DeficiencyGermany
-
National Taiwan University HospitalRecruiting
-
Klinikum Chemnitz gGmbHInstitute of Anatomy TU DresdenCompletedLimbal Stem-cell Deficiency
-
Royan InstituteSmall Business Developing Center; Labafi Nejad Eye Research CenterCompletedLimbal Stem Cell DeficiencyIran, Islamic Republic of
-
Royan InstituteCompletedLimbal Stem Cell Deficiency (LSCD)
-
RHEACELL GmbH & Co. KGFGK Clinical Research GmbH; Ticeba GmbH; Granzer Regulatory Consulting & ServicesActive, not recruitingLimbal Stem Cell DeficiencyUnited States, Germany
Clinical Trials on Surgical transplantation of ACCE
-
Translational Research Center for Medical Innovation...Nagoya University; ArBlast Co.,Ltd.Completed
-
CellSeed France S.A.R.L.FGK Clinical Research GmbHWithdrawnLimbal Stem Cell DeficiencyGermany
-
University of PittsburghU.S. Army Medical Research and Development Command; San Antonio Military Medical... and other collaboratorsTerminated
-
University Hospital, GhentCompleted
-
Chinese Academy of SciencesFirst Hospitals affiliated to the China PLA General HospitalUnknown
-
University Hospital, LilleInstitut National de la Santé Et de la Recherche Médicale, FranceCompletedType 1 Diabetes | Organ Transplantation | ImmunosuppressionFrance
-
M.D. Anderson Cancer CenterRecruitingPancreatic Ductal AdenocarcinomaUnited States
-
M.D. Anderson Cancer CenterRecruitingMetastatic Malignant Neoplasm in the Liver | Primary Malignant Liver Neoplasm | Liver and Intrahepatic Bile Duct NeoplasmUnited States
-
Qazvin University Of Medical SciencesUnknownOral Lichen PlanusIran, Islamic Republic of
-
Jakub AntczakCentrum Neurologii Klinicznej Krakowska Akademia NeurologiiCompletedCarpal Tunnel SyndromePoland